Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders

Biological Psychiatry

Volumn 78, Issue 4, 2015, Pages 270-277

  Miskowiak, Kamilla W ^a,c   Vinberg, Maj ^a   Macoveanu, Julian ^a,c   Ehrenreich, Hannelore ^b   Køster, Nicolai ^a   Inkster, Becky ^e   Paulson, Olaf B ^a,c   Kessing, Lars V ^a   Skimminge, Arnold ^c   Siebner, Hartwig R ^c,d  

^a Rigshospitalet   (Denmark)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c HVIDOVRE HOSPITAL   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bipolar disorder; Cognition; Erythropoietin; Hippocampus; MRI; Treatment resistant depression

Indexed keywords

ERYTHROPOIETIN; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; GRAY MATTER; HAMILTON DEPRESSION RATING SCALE; HEMATOCRIT; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY ASSESSMENT; MEMORY DISORDER; MOOD CHANGE; MOOD DISORDER; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; REMISSION; REY AUDITORY VERBAL LEARNING TEST; SUBICULUM; TREATMENT RESISTANT DEPRESSION; VERBAL MEMORY; YOUNG MANIA RATING SCALE; CLINICAL TRIAL; DEPRESSIVE DISORDER; DRUG EFFECTS; HIPPOCAMPUS; MEMORY; MIDDLE AGED; MOOD DISORDERS; PATHOLOGY; PSYCHOLOGICAL RATING SCALE;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ERYTHROPOIETIN; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES;

EID: 84937546189     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.12.013     Document Type: Article

References (43)

1. J. Olesen, A. Gustavsson, M. Svensson, H.U. Wittchen, and B. Jonsson The economic cost of brain disorders in Europe Eur J Neurol 19 2012 155 162
2. R.J. Wyatt, and I. Henter An economic evaluation of manic-depressive illness - 1991 Soc Psychiatry Psychiatr Epidemiol 30 1995 213 219
3. J. Jaeger, S. Berns, S. Uzelac, and S. Davis-Conway Neurocognitive deficits and disability in major depressive disorder Psychiatry Res 145 2006 39 48
4. M. Mur, M.J. Portella, A. Martinez-Aran, J. Pifarre, and E. Vieta Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients Psychopathology 42 2009 148 156
5. V.V. Dias, V. Balanza-Martinez, M.G. Soeiro-de-Souza, R.A. Moreno, M.L. Figueira, R. Machado-Vieira, and E. Vieta Pharmacological approaches in bipolar disorders and the impact on cognition: A critical overview Acta Psychiatr Scand 126 2012 315 331
6. E.J. Canales-Rodriguez, E. Pomarol-Clotet, J. Radua, S. Sarro, S. Alonso-Lana, C. del Mar Bonnin, and et al. Structural abnormalities in bipolar euthymia: A multicontrast molecular diffusion imaging study Biol Psychiatry 76 2014 239 248
7. M.C. McKinnon, K. Yucel, A. Nazarov, and G.M. MacQueen A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder J Psychiatry Neurosci 34 2009 41 54
8. J. Cole, A.W. Toga, C. Hojatkashani, P. Thompson, S.G. Costafreda, A.J. Cleare, and et al. Subregional hippocampal deformations in major depressive disorder J Affect Disord 126 2010 272 277
9. T. Elvsashagen, L.T. Westlye, E. Boen, P.K. Hol, S. Andersson, O.A. Andreassen, and et al. Evidence for reduced dentate gyrus and fimbria volume in bipolar II disorder Bipolar Disord 15 2013 167 176
10. Y. Huang, N.J. Coupland, R.M. Lebel, R. Carter, P. Seres, A.H. Wilman, and N.V. Malykhin Structural changes in hippocampal subfields in major depressive disorder: A high-field magnetic resonance imaging study Biol Psychiatry 74 2013 62 68
11. P.J. Lucassen, M.B. Muller, F. Holsboer, J. Bauer, A. Holtrop, J. Wouda, and et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure Am J Pathol 158 2001 453 468
12. D.N. Alfarez, H. Karst, E.H. Velzing, M. Joels, and H.J. Krugers Opposite effects of glucocorticoid receptor activation on hippocampal CA1 dendritic complexity in chronically stressed and handled animals Hippocampus 18 2008 20 28
13. B. Czeh, and P.J. Lucassen What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 257 2007 250 260
14. I. Hageman, M. Nielsen, G. Wortwein, N.H. Diemer, and M.B. Jorgensen Electroconvulsive stimulations prevent stress-induced morphological changes in the hippocampus Stress 11 2008 282 289
15. J.A. Cobb, J. Simpson, G.J. Mahajan, J.C. Overholser, G.J. Jurjus, L. Dieter, and et al. Hippocampal volume and total cell numbers in major depressive disorder J Psychiatr Res 47 2013 299 306
16. C.A. Stockmeier, and G. Rajkowska Cellular abnormalities in depression: Evidence from postmortem brain tissue Dialogues Clin Neurosci 6 2004 185 197
17. D. Sargin, H. Friedrichs, A. El-Kordi, and H. Ehrenreich Erythropoietin as neuroprotective and neuroregenerative treatment strategy: Comprehensive overview of 12 years of preclinical and clinical research Best Pract Res Clin Anaesthesiol 24 2010 573 594
18. M.J. Girgenti, J. Hunsberger, C.H. Duman, M. Sathyanesan, R. Terwilliger, and S.S. Newton Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects Biol Psychiatry 66 2009 267 274
19. B. Adamcio, D. Sargin, A. Stradomska, L. Medrihan, C. Gertler, F. Theis, and et al. Erythropoietin enhances hippocampal long-term potentiation and memory BMC Biol 6 2008 37
20. H. Ehrenreich, D. Hinze-Selch, S. Stawicki, C. Aust, S. Knolle-Veentjer, S. Wilms, and et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin Mol Psychiatry 12 2007 206 220
21. H. Ehrenreich, B. Fischer, C. Norra, F. Schellenberger, N. Stender, M. Stiefel, and et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis Brain 130 2007 2577 2588
22. K.W. Miskowiak, M. Vinberg, C.J. Harmer, H. Ehrenreich, and L.V. Kessing Erythropoietin: A candidate treatment for mood symptoms and memory dysfunction in depression Psychopharmacology (Berl) 219 2012 687 698
23. K.W. Miskowiak, M. Vinberg, E.M. Christensen, J.D. Bukh, C.J. Harmer, H. Ehrenreich, and L.V. Kessing Recombinant human erythropoietin for treating treatment-resistant depression: A double-blind, randomized, placebo-controlled phase 2 trial Neuropsychopharmacology 39 2014 1399 1408
24. K. Miskowiak, H. Ehrenreich, E.M. Christensen, L.V. Kessing, and M. Vinberg Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: A double-blind, randomized, placebo-controlled phase 2 trial J Clin Psychiatry 75 2014 1347 1355
25. T. Wustenberg, M. Begemann, C. Bartels, O. Gefeller, S. Stawicki, D. Hinze-Selch, and et al. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia Mol Psychiatry 16 2011 26 36
26. B. Patenaude, S.M. Smith, D.N. Kennedy, and M. Jenkinson A Bayesian model of shape and appearance for subcortical brain segmentation Neuroimage 56 2011 907 922
27. S.M. Smith, M. Jenkinson, M.W. Woolrich, C.F. Beckmann, T.E. Behrens, H. Johansen-Berg, and et al. Advances in functional and structural MR image analysis and implementation as FSL Neuroimage 23 suppl 1 2004 S208 S219
28. W.S. Tae, S.S. Kim, K.U. Lee, E.C. Nam, J.W. Choi, and J.I. Park Hippocampal shape deformation in female patients with unremitting major depressive disorder AJNR Am J Neuroradiol 32 2011 671 676
29. K. Yucel, M.C. McKinnon, V.H. Taylor, K. Macdonald, M. Alda, L.T. Young, and G.M. MacQueen Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: A longitudinal MRI study Psychopharmacology (Berl) 195 2007 357 367
30. J.M. Bessa, D. Ferreira, I. Melo, F. Marques, J.J. Cerqueira, J.A. Palha, and et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling Mol Psychiatry 14 2009 764 773
31. T. Hajszan, A. Dow, J.L. Warner-Schmidt, K. Szigeti-Buck, N.L. Sallam, A. Parducz, and et al. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression Biol Psychiatry 65 2009 392 400
32. A.M. Magarinos, A. Deslandes, and B.S. McEwen Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress Eur J Pharmacol 371 1999 113 122
33. B.N. Frey, A.C. Andreazza, A.R. Rosa, M.R. Martins, S.S. Valvassori, G.Z. Reus, and et al. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania Behav Pharmacol 17 2006 311 318
34. T. Fukumoto, S. Morinobu, Y. Okamoto, A. Kagaya, and S. Yamawaki Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain Psychopharmacology (Berl) 158 2001 100 106
35. G. Chen, G. Rajkowska, F. Du, N. Seraji-Bozorgzad, and H.K. Manji Enhancement of hippocampal neurogenesis by lithium J Neurochem 75 2000 1729 1734
36. D.H. Oh, I.Y. Lee, M. Choi, S.H. Kim, and H. Son Comparison of neurite outgrowth induced by erythropoietin (EPO) and carbamylated erythropoietin (CEPO) in hippocampal neural progenitor cells Korean J Physiol Pharmacol 16 2012 281 285
37. A. Sarrieau, M. Dussaillant, F. Agid, D. Philibert, Y. Agid, and W. Rostene Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain J Steroid Biochem 25 1986 717 721
38. X.H. Ge, G.J. Zhu, D.Q. Geng, Z.J. Zhang, and C.F. Liu Erythropoietin attenuates 6-hydroxydopamine-induced apoptosis via glycogen synthase kinase 3beta-mediated mitochondrial translocation of Bax in PC12 cells Neurol Sci 33 2012 1249 1256
39. B. Inkster, T.E. Nichols, P.G. Saemann, D.P. Auer, F. Holsboer, P. Muglia, and P.M. Matthews Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder Arch Gen Psychiatry 66 2009 721 728
40. T. Frodl, M. Jager, I. Smajstrlova, C. Born, R. Bottlender, T. Palladino, and et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: A 3-year prospective magnetic resonance imaging study J Psychiatry Neurosci 33 2008 423 430
41. R.A. Menke, K. Szewczyk-Krolikowski, S. Jbabdi, M. Jenkinson, K. Talbot, C.E. Mackay, and M. Hu Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson's disease Hum Brain Mapp 35 2014 1681 1690
42. R.A. Morey, C.M. Petty, Y. Xu, J.P. Hayes, H.R. Wagner 2nd, D.V. Lewis, and et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes Neuroimage 45 2009 855 866
43. A. Mechelli, C.J. Price, K.J. Friston, and J. Ashburner Voxel-based morphometry of the human brain: Methods and applications Curr Med Imaging Rev 1 2005 1 9